Micronbrane Medical | Metagenomic Innovations from Collection to Action

Company Overview

Metagenomic Innovations from Collection to Action

Micronbrane Medical develops genomic innovations that enrich our understanding of microorganisms that influence human health and ensure sustainability.

The company's proprietary technologies include special collection devices, novel host depletion, optimized reagents, advanced metagenomic sequencing assays, plus rapid bioinformatic analysis software.

The combined Micronbrane Medical solution enables fast and accurate identification and monitoring of a broad range of microorganisms, including bacteria, fungi, viruses, and parasites.

Headquartered in Taiwan, the company has partnerships and collaborations with leading academic institutions, health systems, and clinical laboratories worldwide, underscoring its commitment to transforming our interactions with the microbial world.

Devin™ Host Depletion Filter

The Devin Host Depletion syringe filter utilizes a patented Zwitterionic Interface ultra-Self-assemble Coating (ZISC) to capture over 99% of host nucleated cells without relying on size exclusion.

● NOT size exclusion (pore size is 15-20µm)

● < 5 min processing time

● >99% leukocyte depletion

● >90% microbial output

● Applicable for all liquid biopsies

● Volumes from 50µl to 10ml

Devin™ Microbial DNA Enrichment Kit

The Devin Microbial DNA Enrichment Kit supports multiple genomic applications including mNGS, 16S rRNA sequencing, qPCR, and end-point PCR.

● mNGS — grade reagents

● Fast, efficient and cost-effective

● Enhance microbial reads by 10 to 1000 fold

● Accelerate the extraction process to 1.5 hours

● Optimized extraction of both Gram - and Gram + bacteria

● Ensures high-yield genomic DNA for downstream analysis

● Available for manual and automated workflows

Unison Ultralow DNA NGS Library Preparation Kit

The Unison Ultralow DNA NGS Library Preparation Kit is designed for efficient library preparation with a proprietary Tn5 process optimized for Illumina sequencing platforms.

● Industry leading DNA input requirement (as low as 10 pg)

● Pathogen identification in 5 million reads

● AMR gene profiling with deeper reads

● Minimizes hands-on time (45 minutes) and total processing times (150 minutes)